- CAR-T Cell Therapy Achieves Near-Complete Tumor Regression in Brain Cancer After Five Days Good News Network
- ‘Nothing else that has had this effect’: New treatment shrinks brain tumors in small clinical trial at Mass. General The Boston Globe
- Early clinical trial results show ‘dramatic and rapid’ regression of glioblastoma after next generation CAR-T therapy Medical Xpress
- Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors CNN
- Designer immune-cell therapy could shrink deadly brain tumors, early trials show Livescience.com
Read original article here